These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34560199)

  • 1. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.
    Cannon A; Thompson CM; Bhatia R; Kandy RRK; Solheim JC; Batra SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188628. PubMed ID: 34560199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
    Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
    Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
    Yang C; Zheng W; Du W
    Oncol Rep; 2016 Sep; 36(3):1686-92. PubMed ID: 27461521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
    Smith JS; Alagesan P; Desai NK; Pack TF; Wu JH; Inoue A; Freedman NJ; Rajagopal S
    Mol Pharmacol; 2017 Aug; 92(2):136-150. PubMed ID: 28559424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
    Berchiche YA; Sakmar TP
    Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
    Wu Q; Dhir R; Wells A
    Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
    Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3, a double-edged sword in tumor progression and angiogenesis.
    Billottet C; Quemener C; Bikfalvi A
    Biochim Biophys Acta; 2013 Dec; 1836(2):287-95. PubMed ID: 23994549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
    Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
    J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
    Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
    Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
    Shen D; Cao X
    Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
    Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
    J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
    Struyf S; Salogni L; Burdick MD; Vandercappellen J; Gouwy M; Noppen S; Proost P; Opdenakker G; Parmentier M; Gerard C; Sozzani S; Strieter RM; Van Damme J
    Blood; 2011 Jan; 117(2):480-8. PubMed ID: 20980681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer.
    Kuo PT; Zeng Z; Salim N; Mattarollo S; Wells JW; Leggatt GR
    Front Med (Lausanne); 2018; 5():271. PubMed ID: 30320116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
    Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
    Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.
    Zhu G; Yan HH; Pang Y; Jian J; Achyut BR; Liang X; Weiss JM; Wiltrout RH; Hollander MC; Yang L
    Oncotarget; 2015 Dec; 6(41):43408-19. PubMed ID: 26485767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.
    Kundu N; Ma X; Brox R; Fan X; Kochel T; Reader J; Tschammer N; Fulton A
    Breast Cancer (Auckl); 2019; 13():1178223419873628. PubMed ID: 31619923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR3A promotes the secretion of the antifibrotic decoy receptor sIL-13Rα2 by pulmonary fibroblasts.
    Worrell JC; Walsh SM; Fabre A; Kane R; Hinz B; Keane MP
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1059-C1069. PubMed ID: 33026833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.